At Dana-Farber Cancer Institute, we believe that skin color, income, and zip code should never determine health outcomes. Hear from Narjust Florez, MD, Associate Director of Dana Farber’s Cancer Care Equity Program, as she leads a discussion about the Institute’s efforts to translate research into clinical interventions that will reduce disparities in cancer outcomes. Leading clinicians and investigators in the fields of pediatric, breast, gastrointestinal, and thoracic oncology discuss how they are working to ensure that all patients can benefit from lifesaving advancements at Dana-Farber and beyond. Panelists include Kira Bona, MD, MPH, Rachel Freedman, MD, MPH, and Nadine McCleary, MD, MPH.